Literature DB >> 16199653

ACOG practice bulletin. Clinical management guidelines of obstetrician-gynecologists. Number 67, October 2005. Medical management of abortion.

.   

Abstract

Over the past two decades, medical methods of abortion have been developed throughout the world and are now used in the United States. Medical abortion, which involves the use of medications to induce an abortion rather than a surgical abortion, is an option for women who wish to terminate a pregnancy up to 63 days of gestation (calculated from the first day of the last menstrual period). Medical abortions currently account for 6% of all abortions in the United States (1). The purpose of this document is to present evidence of the effectiveness, benefits, and risks of medical abortion and provide a framework for the evaluation and counseling of women who are considering medical abortion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199653     DOI: 10.1097/00006250-200510000-00051

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.

Authors:  Karen Pazol; Andreea A Creanga; Suzanne B Zane
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Mortality associated with mifepristone-misoprostol medical abortion.

Authors:  Mitchell Creinin; Paul Blumenthal; Lee Shulman
Journal:  MedGenMed       Date:  2006-04-27

3.  Rates of serious infection after changes in regimens for medical abortion.

Authors:  Mary Fjerstad; James Trussell; Irving Sivin; E Steve Lichtenberg; Vanessa Cullins
Journal:  N Engl J Med       Date:  2009-07-09       Impact factor: 91.245

4.  Significant adverse events and outcomes after medical abortion.

Authors:  Kelly Cleland; Mitchell D Creinin; Deborah Nucatola; Montsine Nshom; James Trussell
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

5.  The effectiveness of using misoprostol with and without letrozole for successful medical abortion: A randomized placebo-controlled clinical trial.

Authors:  Elham Naghshineh; Zahra Allame; Faezah Farhat
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

6.  Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.

Authors:  Ushma D Upadhyay; Nicole E Johns; Sarah L Combellick; Julia E Kohn; Lisa M Keder; Sarah C M Roberts
Journal:  PLoS Med       Date:  2016-08-30       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.